Moderna CEO Stéphane Bancel stated in an interview on Thursday that there is a 20% risk that new Covid versions…
Moderna, an American biotechnology company, submitted an emergency use authorization (EUA) request to the US Food and Drug Administration (FDA)…
Millions of people died around the world as a result of the coronavirus illness (COVID-19) pandemic. Non-pharmaceutical interventions were initially…
Moderna's anti-Covid vaccination was authorised by the European Union's medicines authority on Thursday for children aged six to eleven, making…
The CEO of US biotech firm Moderna (MRNA.O) told Reuters that an Omicron-specific booster vaccine could be ready by August,…
Moderna's coronavirus vaccine, the second most extensively used in the United States and the second to get full regulatory approval,…
Moderna Inc has begun a mid-stage trial to test a booster dose of its COVID-19 vaccine, which is specially tailored…
According to a peer-reviewed study, Omicron can circumvent the immunological protection provided by COVID-19 vaccines as well as natural infection,…
According to a research, the Moderna COVID-19 vaccine is 87% successful in avoiding infection, 95% effective in preventing severe illness,…
Moderna's CEO warned on Tuesday that COVID-19 vaccines are unlikely to be as effective against the Omicron strain as they…